Miércoles, 30 de Mayo de 2012

Sesión de control

Rajoy dice que con la crisis es muy difícil aprobar enmiendas a los PGE

Precio	Variación	Volumen (títulos)	Volumen ($)	Hora
32,640$	+6,42% +1,970$	35.843.367	988.872.162,22	22:00:24

Noticias M. Continuo

Merck to pay $950 million to settle U.S. Vioxx charge

23/11

By Anna Yukhananov

Merck to pay $950 million to settle U.S. Vioxx charge

22/11

By Anna Yukhananov

Merck to pay about $950 million to settle U.S. Vioxx charge

22/11

(Reuters) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.

Merck to pay nearly $1 billion to settle U.S. charges

22/11

(Reuters) - Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.

Caterpillar, Merck results boost stock futures

21/07

By Rodrigo Campos

Caterpillar, Merck results boost futures

21/07

By Rodrigo Campos

Merck to buy Schering-Plough for $41.1 billion

9/03

By Edward Tobin and Ransdell Pierson

Merck to buy Schering-Plough for $41.1 billion

9/03

By Edward Tobin and Ransdell Pierson

Merck to buy Schering-Plough for $41.1 billion

9/03

By Edward Tobin and Ransdell Pierson

Wall Street down as bank woes offset Merck deal

9/03

NEW YORK (Reuters) - Stocks fell at the open on Monday as a lack of confidence in steps to shore up ailing banks persisted, offsetting Merck's proposed takeover of Schering-Plough .